In Vitro Display Library Screening for Native Protein Binding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for screening in vitro display libraries for binding to protein or RNA targets are often performed on purified, recombinant proteins outside a cellular context, which can result in binding entities that lack biological relevance due to non-native conformations and missing cofactors, limiting their effectiveness for drug discovery.
Innovation Solution
The method involves expressing targets within cells and introducing an in vitro display library, allowing binding entities to interact with native proteins and cofactors, followed by cell lysis to identify binding entities that form complexes with targets, thereby enriching for biologically active compounds.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If binding screening is performed on purified recombinant proteins outside a cellular context, then the screening process is simplified and can be performed with purified components, but the binding entities identified lack biological relevance due to non-native conformations and missing cofactors
Solution Approach 1:
The patent uses an in vitro display library as an intermediary system that bridges the gap between simplified purified protein screening and complex cellular environments. The library consists of binding entities displayed on nucleic acid scaffolds, allowing selection under physiological conditions while maintaining the ability to identify and characterize individual binders through nucleic acid sequencing. This intermediary approach enables screening in a more biologically relevant context without completely sacrificing the simplicity of in vitro methods.
Solution Approach 2:
The patent changes the physical and chemical parameters of the screening environment by moving from purified protein solutions to intracellular conditions. This includes changing the buffer composition to match cellular physiology, maintaining appropriate pH and ionic strength, and allowing the presence of cellular cofactors and metabolites. These parameter changes enable binding entities to interact with targets in a more native-like environment, improving the biological relevance of identified compounds.
2Reliability
If binding screening is performed within a cell to maintain native conformations and cofactors, then biological relevance of binding entities is improved, but the complexity of the screening process increases
Solution Approach 1:
The patent extracts the binding entities from their native cellular context and displays them on artificial nucleic acid scaffolds in an in vitro system. This extraction allows the binding entities to be studied in a controlled environment while retaining their native structure and function. The nucleic acid display technology enables the separation of the binding entity from the complex cellular machinery, allowing for simplified identification and characterization while maintaining biological relevance.
Solution Approach 2:
The in vitro display library system serves multiple functions simultaneously: it maintains native-like binding conditions, enables amplification of binding entities through nucleic acid replication, allows for high-throughput screening, and facilitates identification of binders through sequencing. This multi-functional approach consolidates several complex steps into a unified system, reducing overall process complexity while maintaining biological relevance.
3Productivity
If large libraries of binding entities are screened within cells, then the likelihood of identifying biologically active compounds increases, but the difficulty of detecting and measuring binding events increases
Solution Approach 1:
The patent replaces direct mechanical or physical detection of binding events with a chemical amplification system based on nucleic acid replication. Instead of attempting to directly measure binding events among millions of library members, the system uses the high-fidelity replication capability of nucleic acids to amplify the signal from successful binding events. This substitution transforms a difficult direct measurement problem into a more manageable amplification and detection problem.
Solution Approach 2:
The patent creates copies of binding entities through nucleic acid replication, where each successful binding event results in the amplification of the corresponding nucleic acid sequence. This copying mechanism allows rare binding events to be detected against the background of large library diversity, as the amplified signals from true binders can be distinguished from non-specific binding through sequence analysis and frequency counting.
Data Source
Figure 1
Figure 2
Figure 3A~3D
AI summary
A method for screening of an in vitro display library for binding within a cell of a small-molecule chemical compound binding entity of the library to a protein or RNA target of interest in order to identify at least one individual chemical compound binding entity of the library that is capable of binding within the cell to the protein or RNA target of interest.